MedTrace Logo

A Real-World Evidence Study to Evaluate Oral Health Related Quality of Life Using an Anti-Sensitivity Toothpaste

NCT04964063 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 655

Last updated 2024-01-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate changes in oral health-related quality of life (OHrQoL) in participants suffering from Dentinal Hypersensitivity (DH) symptoms following the use of anti-sensitivity toothpaste for 24 weeks.

Conditions

  • Dentin Sensitivity

Interventions

OTHER

Potassium Nitrate + Sodium Fluoride

Potassium Nitrate 5% weight/weight (w/w) and Sodium Fluoride 0.15% weight/volume (w/v) fluoride ion.

Sponsors & Collaborators

  • HALEON

    lead INDUSTRY

Principal Investigators

  • GSK Clinical Trials · OBVIO HEALTH USA, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-31
Primary Completion
2022-05-13
Completion
2022-05-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04964063 on ClinicalTrials.gov